Canada approves MEG-3 in higher doses, more foods

By Jess Halliday

- Last updated on GMT

Related tags: Omega-3 fatty acid, Eicosapentaenoic acid

Health Canada has expanded its 2003 Novel Foods approval of Ocean
Nutrition's MEG-3 to higher doses and more foods, giving the
microencapsulated fish-oil supplier a head-start on new entrants to
the market.

Ocean Nutrition's branded microencapsulated omega-3 ingredient was first approved for use in Canada in eight foods, and at a dosage of 50mg per serving.

Now, however, following further safety assessment by Health Canada, 100mg per serving is permitted in virtually all foods.

"There is a very limited list of foods MEG-3 cannot be used it,"​ VP marketing and new product development Ian Lucas told NutraIngredients-USA.com.

Lucas said that he is aware not aware of any other microencapsulated omega-3 from fish oil that is approved in Canada.

Omega-3 has been widely studied for a range of benefits, including heart health, cognitive function and joint health. Fish oil is widely agreed to be the best source, since it is rich in DHA (docosahexaenioc acid) and EPA (eicosapentaenoic acid), the most bioavailable forms of the essential fatty acid.

The earlier approval had proved restrictive for some food manufacturers. Other omega-3 containing foods sold in the country use ALA (alpha-linolenic acid), a precursor of DHA/EPA from sources such as flaxseed and linseed. ALA must first be converted by the body before it can be used, and some of the benefit is lost along the way.

Lucas said he expects that some of those companies that have used plant-derived omega-3 up until now in order to get into the market may look to changing to fish oil.

Although this news gives Ocean Nutrition a clear competitive advantage, Lucas is under no illusions that this will last forever.

"In the future, through the right steps, other suppliers will be able to get their ingredients approved as well,"​ he said. But it is expected to be at least a year before this comes to pass.

Related news

Show more

Related products

show more

Clinically Proven Omega-3 formula for Joint Health

Clinically Proven Omega-3 formula for Joint Health

KD Pharma Group | 29-Apr-2019 | Data Sheet

KD Nutra is pleased to announce the completion of a clinical trial for its Move3™ omega-3 joint formulation. The trial has shown that Move3™ has a significant...

MenaQ7® Partners Benefit From K2 Outreach

MenaQ7® Partners Benefit From K2 Outreach

NattoPharma USA, Inc. | 22-Apr-2019 | Case Study

MenaQ7® K2 as MK-7 provides health benefits for all ages. That is a fact clinically proven by NattoPharma and communicated to practitioners and consumers...

Outsmart brain-ageing in healthy older adults

Outsmart brain-ageing in healthy older adults

DIANA, FOOD DIVISION | 02-Apr-2019 | Technical / White Paper

What happens when you combine the brain health benefits of blueberries with those of grapes?
Both Canadian wild blueberries and French grapes are...

Related suppliers

Follow us

Featured Events

View more

Products

View more

Webinars